Comparison of healthcare resource use and treatment among prostate cancer patients with and without DNA damage repair gene mutations.

被引：0
|
作者：
Liu, Jinan
Near, Aimee
Chiarappa, Joseph A.
Wada, Keiko
Tse, Jenny
Burudpakdee, Chakkarin
Behl, Ajay S.
Antonarakis, Emmanuel S.
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] IQVIA, Durham, NC USA
[3] IQVIA, Fairfax, VA USA
[4] IQVIA, Cambridge, MA USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17059
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment outcomes for patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) pts and DNA damage repair gene mutations.
    Yip, Steven
    Angeles, Arkhjamil
    Beigi, Arshia
    Warner, Evan W.
    Khalaf, Daniel
    Sunderland, Katherine
    Vandekerkhove, Gillian Rae
    Annala, Matti
    Schrader, Kasmintan A.
    Wyatt, Alexander William
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Treatment outcomes in metastatic prostate cancer patients with DNA damage repair mutations
    Kwon, Daniel
    Wright, Francis
    Zhang, Li
    Chou, Jonathan
    Borno, Hala
    Desai, Arpita
    Oh, David Yoonsuk
    Pollock, YaoYao Guan
    Bose, Rohit
    Huang, Franklin W.
    Hope, Thomas
    Friedlander, Terence W.
    Fong, Lawrence
    Feng, Felix Y.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations.
    Carlo, Maria Isabel
    Kemel, Yelena
    Breen, Kelsey
    Cadoo, Karen Anne
    Walsh, Michael Francis
    Abida, Wassim
    Autio, Karen A.
    Danila, Daniel Costin
    Kampel, Lewis J.
    Morris, Michael J.
    Rathkopf, Dana E.
    Slovin, Susan F.
    Solit, David B.
    Offit, Kenneth
    Stadler, Zsofia Kinga
    Scher, Howard I.
    Robson, Mark E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [4] Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations
    Chau, Vincent
    Madan, Ravi A.
    Bilusic, Marijo
    Owens, Helen
    Cordes, Lisa M.
    Marte, Jennifer L.
    Gulley, James L.
    Lee, Jung -Min
    Dahut, William L.
    Karzai, Fatima
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : E352 - E359
  • [5] Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer
    Borbiev, Talaibek
    Babcock, Kevin
    Sinopole, Kayleigh
    Chesnut, Gregory T.
    Petrovics, Gyorgy
    CANCERS, 2025, 17 (04)
  • [6] Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations
    Lakritz, Stephanie
    Nicklawsky, Andrew
    Alami, Vida
    Kohli, Manish
    Moskaluk, Chris
    Riedlinger, Greg
    Salhia, Bodour
    Singer, Eric A.
    Naqash, Abdul Rafeh
    Nepple, Ken
    Edge, Stephen
    Myint, Zin
    Kolesar, Jill
    Adra, Nabil
    Flaig, Thomas
    Graham, Laura S.
    CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
  • [7] A phase I study of carboplatin and talazoparib in patients with and without DNA repair mutations.
    Dhawan, Mallika Sachdev
    Bartelink, Imke Heleen
    Aggarwal, Rahul Raj
    Leng, Jim
    Kelley, Robin Kate
    Melisko, Michelle E.
    Ryan, Charles J.
    Thomas, Scott
    Munster, Pamela N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] GERMLINE DNA DAMAGE REPAIR GENE MUTATIONS IN EARLY STAGE PROSTATE CANCER PATIENTS UNDERGOING ACTIVE SURVEILLANCE OR DEFINITIVE LOCAL TREATMENT
    Kearns, James T.
    Nielsen, Sarah M.
    Russell, Emily M.
    Moretz, Chad
    Esplin, Edward D.
    Korn, Michael
    Helfand, Brian T.
    Eggener, Scott E.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E680 - E680
  • [9] Germline DNA repair gene mutations in Taiwan prostate cancer patients.
    Huang, Wilson
    Yeh, Shauh-Der
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] TRIUMPH: Phase II trial of rucaparib monotherapy in patients with metastatic hormonesensitive prostate cancer harboring germline DNA repair gene mutations.
    Markowski, Mark Christopher
    Sternberg, Cora N.
    Wang, Hao
    Sullivan, Rana
    King, Serina
    Lotan, Tamara L.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345